Browsing Tag
uveal melanoma
3 posts
IDEAYA and Servier start Phase III adjuvant uveal melanoma study
IDEAYA and Servier have dosed the first patient in the 450-person OptimUM-11 Phase III study, extending darovasertib plus crizotinib into primary uveal melanoma before the combination’s metastatic indication has completed regulatory review.
Breakthrough study reveals Delcath Systems’ therapy doubles survival for uveal melanoma patients
Delcath Systems, Inc. (Nasdaq: DCTH), a pioneering company in interventional oncology, has announced promising results from a recent…
TriSalus Life Sciences’ SD-101 yields positive outcomes from Phase 1 trial in uveal melanoma with liver metastases
TriSalus Life Sciences made a significant contribution to the Society of Immunotherapy for Cancer (SITC) 2023 Annual Meeting…